Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Beckley Psytech Partners With Empatica To Deliver Personalized Consumer Monitoring For Clinical Trial Of Psychedelic For Treatment Resistant Depression

Beckley Psytech Limited, which uses psychedelic medicines to treat neurological and psychiatric disorders, partnered with Empatica, Inc., which provides a remote monitoring wearable device for people with neurological conditions. The partnership is intended to collect and analyze behavioral and physiological data in Beckley Psytech’s future clinical trials. This partnership will utilize Empatica’s medical-grade EmbracePlus wearable and software, to identify and measure passive behavioral and physiological signals among people participating in a Phase 2 clinical trial. Beckley Psytech is evaluating the use of 5-MeO-DMT in combination with psychotherapy in the treatment of treatment resistant depression (TRD . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!